Abstract
Recent studies on the mechanism by which disulfiram inhibits aldehyde dehydrogenase have provided evidence for the formation of reactive intermediates that are thought to carbamoylate, and thereby inactivate the enzyme. In our study, rats were dosed with either disulfiram (0.25 mmol kg− 1 i.p.) or its reduced metabolite diethyldithiocarbamate (DDTC; 0.5 mmol kg− 1i.p.) and urine was collected for the analysis of metabolites derived from putative reactive intermediates. By means of ionspray LC-MS/MS, two novel N-acetylcysteine (NAC) conjugates,i.e.,N-acetyl-S-(N, N-diethylcarbamoyl)cysteine andN-acetyl-S-(N, N-diethylthiocarbamoyl)cysteine, were identified in urine specimens. Quantitative analyses indicated that, over the 0- to 24-hr period after drug administration, urinary excretion ofN-acetyl-S-(N, N-diethylcarbamoyl)cysteine accounted for 7.5 ± 4.0 and 6.2 ± 1.0%, respectively, of the dose of disulfiram and diethyldithiocarbamate, while the corresponding thiocarbamoyl conjugate, N-acetyl-S-(N, N-diethylthiocarbamoyl)cysteine, accounted for a further 0.5 ± 0.3 and 0.3 ± 0.1%, respectively, of the dose. These conjugates are believed to derive from reactive sulfoxide and sulfone metabolites of disulfiram, namely S-methyl-N, N-diethylthiocarbamate sulfoxide (DETC-MeSO),S-methyl-N, N-diethylthiocarbamate sulfone (DETC-MeSO2), S-methyl-N,N-diethyldithiocarbamate sulfoxide (DDTC-MeSO) andS-methyl-N, N-diethyldithiocarbamate sulfone (DDTC-MeSO2), which were found to carbamoylateN-acetylcysteine in vitro with the following rank order of reactivity: DDTC-MeSO2 > DETC-MeSO2 > DDTC-MeSO > DETC-MeSO. In vitro experiments with aldehyde dehydrogenase showed that all four S-oxygenated metabolites inhibited the enzyme effectively. Furthermore, inclusion of NAC in incubation media attenuated significantly the inhibition by DDTC-MeSO2, DETC-MeSO2 and DDTC-MeSO, but had little effect on that by DETC-MeSO. Our results are consistent with the hypothesis that disulfiram and diethyldithiocarbamate undergo activation by a sequence of metabolic reactions leading to the formation of electrophilicS-methyl sulfoxides and sulfones that carbamoylate, and thereby inhibit, aldehyde dehydrogenase and possibly other enzymes.
Footnotes
-
Send reprint requests to: Dr. Thomas A. Baillie, Department of Drug Metabolism, Merck Research Laboratories, WP26A-2044, West Point, PA 19486.
-
↵1 This work was supported by Grant ES05500 from the National Institutes of Health.
-
↵2 Current address: Clinical Pharmacological Center, Peking Union Medical College, Beijing, China 100730.
-
↵3 Current address: Department of Drug Metabolism, Merck Research Laboratories, WP26A-2044, West Point, PA 19486.
- Abbreviations:
- ALDH
- aldehyde dehydrogenase
- NAC
- N-acetylcysteine
- APrCC
- N-acetyl-S-(N-propylcarbamoyl)cysteine
- ADECC
- N-acetyl-S-(N, N-diethylcarbamoyl)cysteine
- ADETCC
- N-acetyl-S-(N, N-diethylthiocarbamoyl)cysteine
- DDTC
- diethyldithiocarbamate
- DDTC-Me
- S-methyl-N, N-diethyldithiocarbamate
- DDTC-MeSO
- S-methyl-N, N-diethyldithiocarbamate sulfoxide
- DDTC-MeSO2
- S-methyl-N, N-diethyldithiocarbamate sulfone
- DETC-Me
- S-methyl-N, N-diethylthiocarbamate
- DETC-MeSO
- S-methyl-N, N-diethylthiocarbamate sulfoxide
- DETC-MeSO2
- S-methyl-N, N-diethylthiocarbamate sulfone
- EPTC
- S-ethyl-N, N-dipropylthiocarbamate
- SDEG
- S-(N, N-diethylcarbamoyl)glutathione
- SDETG
- S-(N, N-diethylthiocarbamoyl)glutathione
- TFA
- trifluoroacetic acid
- LC-MS/MS
- liquid chromatography-tandem mass spectrometry
- CID
- collisionally-induced dissociation
- SRM
- selected reaction monitoring
- FMO
- flavin-containing monooxygenases
- Received July 24, 1996.
- Accepted December 16, 1996.
- The American Society for Pharmacology and Experimental Therapeutics
JPET articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|